Department of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China.
Department of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
Int J Nanomedicine. 2020 Feb 17;15:1059-1071. doi: 10.2147/IJN.S237544. eCollection 2020.
Aptamers are a class of targeting ligands that bind exclusively to biomarkers of interest. Aptamers have been identified as candidates for the construction of various smart systems for therapy, diagnosis, bioimaging, and drug delivery due to their high target affinity and specificity. Aptamers are accounted as chemical antibodies that can be readily linked to drugs, sensors, signal enhancers, or nanocarriers for functionalization. Use of aptamer-guided medications, especially nanomedicines, has resulted in encouraging outcomes compared to those use of aptamer-free counterparts. This article reviews recent advances in the use of aptamers as targeting ligands for various biomedical and pharmaceutical purposes. Special interests focus on aptamer-based theranostics, biosensing, bioimaging, drug potentiation, and targeted drug delivery.
适体是一类靶向配体,能专一地与感兴趣的生物标志物结合。由于其高靶亲和力和特异性,适体已被鉴定为构建各种智能治疗、诊断、生物成像和药物输送系统的候选物。适体被认为是化学抗体,可以很容易地与药物、传感器、信号增强剂或纳米载体连接,以实现功能化。与无适体对照物相比,使用适体导向药物,特别是纳米药物,已取得令人鼓舞的结果。本文综述了适体作为各种生物医学和药物用途的靶向配体的最新进展。特别关注基于适体的治疗学、生物传感、生物成像、药物增效和靶向药物输送。